Moderna
Moderna, Inc., an American biotech firm, specializes in developing mRNA therapeutics and vaccines for various diseases.
Founded
2010Moderna, Inc., an American biotech firm, specializes in developing mRNA therapeutics and vaccines for various diseases.
Founded in September 2010, Moderna, Inc. is an American biotechnology company headquartered in Cambridge, Massachusetts. The company was established by Derrick Rossi, Timothy A. Springer, Robert S. Langer, Kenneth R. Chien, and Noubar Afeyan. Moderna's core mission is to deliver impactful mRNA medicines to address a wide range of diseases, including infectious diseases, immuno-oncology, and cardiovascular conditions. Their innovative approach leverages messenger RNA (mRNA) technology to develop therapeutics and vaccines, aiming to revolutionize the field of medicine.
Notable figures affiliated with Moderna include CEO Stéphane Bancel and Chairman Noubar Afeyan. The company has achieved significant milestones, particularly with the development of its COVID-19 vaccine, which has had a profound global impact. Moderna is publicly traded on Nasdaq under the ticker MRNA and is a component of both the Nasdaq-100 and S&P 500 indices. The company's advancements in mRNA technology have positioned it as a leader in biotechnology, contributing to significant progress in medical science and public health.
Companies similar to Moderna include Rnaimmune, Novavax, Alnylam Pharmaceuticals aln and Combined Therapeutics.
Moderna was founded in 2010.
Moderna's headquarters is located in Cambridge, MA, US.
Moderna's most recent funding round was for $250M (USD) in October 2022.
As of Oct 12, 2022, Moderna has disclosed funding of $3B (USD). Undisclosed round amounts are excluded.
Moderna has 3,900 employees as of Feb 6, 2024.
Combined Therapeutics
combinedtx.com
